Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 29% ± 13% | |
epithelial cell | 10 studies | 27% ± 14% | |
basal cell | 9 studies | 29% ± 10% | |
secretory cell | 5 studies | 22% ± 4% | |
squamous epithelial cell | 3 studies | 47% ± 20% | |
luminal cell of prostate epithelium | 3 studies | 19% ± 3% | |
type I pneumocyte | 3 studies | 25% ± 2% | |
transit amplifying cell | 3 studies | 28% ± 11% | |
keratinocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 1065.21 | 560 / 578 | 98% | 37.25 | 1136 / 1155 |
thymus | 98% | 892.75 | 640 / 653 | 96% | 23.01 | 582 / 605 |
kidney | 100% | 1205.27 | 89 / 89 | 94% | 25.43 | 844 / 901 |
liver | 100% | 1521.16 | 226 / 226 | 81% | 14.10 | 330 / 406 |
prostate | 94% | 1122.80 | 230 / 245 | 87% | 13.02 | 436 / 502 |
esophagus | 64% | 2269.33 | 932 / 1445 | 99% | 65.23 | 182 / 183 |
breast | 64% | 517.71 | 293 / 459 | 97% | 27.29 | 1090 / 1118 |
intestine | 65% | 629.00 | 632 / 966 | 95% | 18.32 | 501 / 527 |
stomach | 66% | 367.04 | 236 / 359 | 94% | 19.08 | 268 / 286 |
pancreas | 57% | 296.33 | 186 / 328 | 95% | 19.62 | 169 / 178 |
bladder | 52% | 722.90 | 11 / 21 | 96% | 26.12 | 482 / 504 |
skin | 72% | 2122.15 | 1305 / 1809 | 32% | 4.57 | 152 / 472 |
tonsil | 0% | 0 | 0 / 0 | 100% | 68.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.55 | 1 / 1 |
uterus | 12% | 96.65 | 20 / 170 | 85% | 46.41 | 392 / 459 |
ovary | 2% | 7.17 | 4 / 180 | 89% | 15.45 | 381 / 430 |
spleen | 72% | 348.79 | 174 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 918.87 | 647 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.54 | 12 / 29 |
adrenal gland | 18% | 72.41 | 47 / 258 | 20% | 2.01 | 47 / 230 |
blood vessel | 24% | 128.44 | 323 / 1335 | 0% | 0 | 0 / 0 |
brain | 6% | 24.21 | 147 / 2642 | 18% | 1.39 | 124 / 705 |
adipose | 22% | 102.02 | 266 / 1204 | 0% | 0 | 0 / 0 |
heart | 21% | 96.24 | 180 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 4.74 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008150 | Biological process | biological_process |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | PRRG4 |
Protein name | Proline rich Gla 4 (Transmembrane) isoform 2 Proline rich Gla 4 (Transmembrane) isoform 3 Proline rich Gla (G-carboxyglutamic acid) 4 (Transmembrane) (Proline rich Gla 4 (Transmembrane) isoform 1) Transmembrane gamma-carboxyglutamic acid protein 4 (Proline-rich gamma-carboxyglutamic acid protein 4) (Proline-rich Gla protein 4) |
Synonyms | PRGP4 hCG_1644711 TMG4 |
Description | FUNCTION: May control axon guidance across the CNS . Prevents the delivery of ROBO1 at the cell surface and down-regulates its expression . . |
Accessions | A0A0S2Z5M6 A0A0S2Z5N9 ENST00000257836.4 Q9BZD6 A0A0S2Z5T7 |